1. A method of promoting hair growth, which comprises:
identifying an individual suffering from hair loss, and
administering to the individual an effective amount for promoting hair growth of a composition comprising:
(1) a sugar compound that is converted to a glycosaminoglycan in the patient;
(2) a primary antioxidant component;
(3) at least one amino acid component; and
(4) at least one transition metal component,
wherein the sugar compound is administered at a dose of from about 40 mg to about 2500 mg per day; the primary antioxidant is administered at a dose of from about 40 mg to about 2400 mg per day; the amino acid is administered at a dose of from about 35 mg to about 1200 mg per day; and the transition metal component is administered at a dose of from about 4.1 mg to about 740 mg per day,
wherein the sugar compound and primary antioxidant component and at least one amino acid component and at least one transition metal component are administered simultaneously.
2. The method of claim 1, wherein the administration is topical.
3. The method of claim 1, wherein the administration is oral.
4. The method of claim 1, wherein the sugar compound and primary antioxidant component and at least one amino acid component and at least one transition metal component are administered simultaneously between 1 and 6 times per day.
5. The method of claim 4, wherein the sugar compound and primary antioxidant component and at least one amino acid component and at least one transition metal component are administered simultaneously 1 time per day.
6. A method of promoting hair growth, which comprises:
identifying an individual suffering from hair loss, and
administering to the individual an effective amount for promoting hair growth of a composition comprising:
(1) a sugar compound that is converted to a glycosaminoglycan in the patient;
(2) a primary antioxidant component;
(3) at least one amino acid component; and
(4) at least one transition metal component,
wherein the sugar compound that is converted to a glycosaminoglycan in the patient; the primary antioxidant component; the at least one amino acid component; and the at least one transition metal component are administered as a pharmaceutical composition comprising:
(1) a sugar compound that is converted to a glycosaminoglycan in the patient in an amount from about 5 to about 50 weight percent of the pharmaceutical composition;
(2) a primary antioxidant component in an amount from about 5 to about 50 weight percent of the pharmaceutical composition;
(3) at least one amino acid component in an amount from about 2 to about 25 weight percent of the pharmaceutical composition; and
(4) at least one transition metal in an amount from about 0.5 to about 15 weight percent of the pharmaceutical composition
wherein the sugar compound that is converted to a glycosaminoglycan in the patient is N- acetylglucosamine or a salt or ester thereof; the primary antioxidant component is ascorbic acid or a salt or ester thereof, the at least one amino acid is selected from the group consisting of proline, lysine, cysteine, and methionine; and the transition metal component is selected from the group consisting of zinc, manganese, copper, and mixtures thereof.
7. The method of claim 6, wherein the transition metal component is selected from the group consisting of zinc monomethionine, manganese ascorbate, and copper sebacate.
8. The method of claim 7, wherein the N-acetylglucosamine or salt or ester thereof; the ascorbic acid or salt or ester thereof; the at least one amino acid component; and either the zinc monomethionine, the manganese ascorbate, or the copper sebacate are administered as a pharmaceutical composition comprising:
(1) N-acetylglucosamine or a salt or ester thereof in an amount from about 5 to about 50 weight percent;
(2) ascorbic acid or a salt or ester thereof in an amount from about 5 to about 50 weight percent;
(3) at least one amino acid component in an amount from about 4 to about 25 weight percent;
(4) zinc monomethionine, if present, in an amount from about 1 to about 10 weight percent;
(5) manganese ascorbate, if present, in an amount from about 1 about 10 weight percent; and
(6) copper sebacate, if present, in an amount from about 0.1 to about 5 weight percent of the composition.
9. The method of claim 1, wherein the individual is suffering from alopecia wherein the administration.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An in-line coaxial circuit assembly, comprising:
a first portion which couples to a second portion;
the coupling of the first portion and the second portion forming an enclosed cylindrical PCB chamber, the PCB chamber coaxial with a longitudinal axis of the assembly;
an inner conductor extending between the first portion and the second portion, positioned along the longitudinal axis, electrically isolated from the first portion and the second portion;
a cylindrical outer conductor sleeve formed in at least one of the first portion and the second portion: the outer conductor sleeve(s) coaxial with the inner conductor, generally isolating the PCB chamber from the inner conductor; and
a PCB in the PCB chamber, the PCB oriented perpendicular to the longitudinal axis of the assembly.
2. An in-line coaxial circuit assembly, comprising:
a first portion having a first electrical connector interface on a first end;
a second portion having a second electrical connector interface on a second end;
the first portion and a second portion adapted to couple together along an outer wall of at least one of the first portion and the second portion;
a cylindrical outer conductor sleeve coaxial with the outer wall formed in at least one of the first portion and the second portion; the coupling of the first portion and the second portion operating to form a generally enclosed cylindrical PCB chamber between the outer conductor sleeve and the outer wall; and a PCB positioned within the PCB chamber.
3. The assembly of claim 2, further including an inner conductor positioned coaxial within the outer conductor sleeve extending between the first electrical connector interface and the second electrical connector interface.
4. The assembly of claim 3, wherein the inner conductor has an in-line dielectric spacer.
5. The assembly of claim 4, wherein the dielectric spacer is a dielectric sleeve positioned between a pin of the inner conductor and one or more spring finger(s) of the inner conductor.
6. An in-line coaxial circuit assembly, comprising:
a first portion having a first electrical connector interface on a first end;
a second portion having a second electrical connector interface on a second end;
the first portion and the second portion adapted to couple together along an outer wall of at least one of the first portion and the second portion;
a cylindrical outer conductor sleeve coaxial with the outer wall; the coupling of the first portion and the second portion operating to form a generally enclosed cylindrical PCB chamber between the outer conductor sleeve and the outer wall;
an inner conductor positioned coaxial within the outer conductor section extending between the first electrical connector interface and the second electrical connector interface; and
a PCB positioned within the PCB chamber, the PCB coupled to the inner conductor through a slot in the outer conductor sleeve.
7. The assembly of claim 6, further including a dielectric spacer between a first end and a second end of the inner conductor.
8. The assembly of claim 6, further including at least one port in one of the first portion and the second portion.
9. The assembly of claim 6, wherein the PCB is ring shaped.
10. The assembly of claim 6, wherein the PCB has a DC bias and surge suppression circuit.
11. The assembly of claim 6, wherein the PCB is coupled to the inner conductor via an inductor.
12. The assembly of claim 11, wherein one end of the inductor is coupled to the inner conductor by a butt solder joint.
13. The assembly of claim 6, wherein the first portion and the second portion coupling is via overlapping portions of the outer wall formed in the first portion and the second portion.
14. The assembly of claim 13, further including threads formed in the overlapping portions of the outer wall.
15. A method for manufacturing an in-line coaxial circuit assembly, comprising the steps of:
forming a first portion having a first electrical connector interface on a first end;
forming a second portion having a second electrical connector interface on a second end;
at least one of the first portion and the second portion having a cylindrical outer conductor sleeve coaxial with an outer wall of at least one of the first portion and the second portion;
positioning an inner conductor coaxial within the outer conductor sleeve, the inner conductor extending between the first electrical connector interface and the second electrical connector interface;
inserting a PCB into a PCB chamber between the outer wall and the outer conductor section;
coupling the PCB to the inner conductor through a slot in the outer conductor section; and
coupling the first portion and the second portion together along the outer wall;
the coupling of the first portion and the second portion generally enclosing the cylindrical PCB chamber between the outer conductor sleeve and the outer wall.
16. The method of claim 15, wherein the inner conductor is formed in two portions separated by a dielectric spacer.
17. The method of claim 15, further including the step of adding at least one output to one of the first portion and the second portion, the output coupled to the PCB.